Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal dominant form of oculocutaneous albinism.
No clinical trials have been registered for autosomal dominant oculocutaneous albinism.
4 publications have been identified in PubMed for autosomal dominant oculocutaneous albinism. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Urushibata H (2026). [PMID: 41797184](https://pubmed.ncbi.nlm.nih.gov/41797184/). *Biochem Biophys Res Commun*. [Basic Science / Preclinical]
Surl D (2026). [PMID: 41705770](https://pubmed.ncbi.nlm.nih.gov/41705770/). *Transl Vis Sci Technol*. [Basic Science / Preclinical]
Zhang Y (2025). [PMID: 40195871](https://pubmed.ncbi.nlm.nih.gov/40195871/). *Pigment Cell Melanoma Res*. [Case Report / Case Series]
Bjeloš M (2024). [PMID: 38928147](https://pubmed.ncbi.nlm.nih.gov/38928147/). *Int J Mol Sci*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:01 AM UTC